AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2019

May 3, 2019

33090_dirs_2019-05-03_1e3a91e2-c0ee-40e4-8fa5-3e1f25fc83c0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2019-05-02

Reporting Person: Silvestro Stephen L (CHIEF COMMERCIAL OFFICER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-02	Unvested Restricted Stock Grant	$	A	90000	Acquired	2024-05-02	Common Stock (90000)	Direct

Footnotes

F1: The Reporting Person received 90,000 shares of the Issuer's restricted stock that will vest all at one time upon completion of 5 years of service.